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Abstract
Background: Adequate counselling on contraceptive methods can help users choose the most appropriate
method. The aim of this study was to assess the effects of structured counselling provided by gynaecologists
on selection of a combined hormonal contraception method.
Methods: Women aged 18–40 years (n = 1871) who were considering the use of a combined hormonal
contraception method (pill, transdermal patch or vaginal ring) underwent a structured counselling session in which
gynaecologists provided comprehensive information. Pre- and post-counselling questionnaires on combined hormonal
contraception choice were completed by participants.
Results: After counselling, many women (38 %) selected a combined hormonal contraception method that was
different from the originally intended one. Preferences for the transdermal patch approximately doubled (from 3.2 %
pre-counselling to 7 %; p < 0.0001) and those for the vaginal ring increased four-fold (from 5.2 to 21.2 %; p < 0.0001),
while preference for the pill remained unchanged (from 64.5 % [pre-] to 64.1 % [post-counselling]). The proportion of
undecided women decreased from 18 to 2.1 % (p < 0.0001). The main reasons for choosing a method were related to
ease of use (all methods), and preferences for administration frequency (daily, weekly or monthly). The number of
patients requiring post-counselling contact with the physician’s office was low (5.1–6.9 %), as was the incidence
of adverse events (1.8–3.1 %).
Conclusions: Counselling has a significant impact on women’s choice of combined hormonal contraception and
encourages them to consider alternative methods to combined oral contraceptives. Moreover, it also enables
women to use their chosen method with confidence.
Trial registration: NCT01181778, Trial registration date: August 12, 2010
Background
Among the numerous contraceptive options available to
women in Western countries, combined oral contracep-
tives (COCs; the daily ‘pill’) remain the most common and
recommended form of reversible contraception, although
with country-specific differences [1–6]. The range of
combined hormonal contraceptive (CHC) options has
increased with development of the transdermal patch and
the vaginal ring. The efficacy and safety of these methods
are similar to those of COCs, but they differ from the pill
in the route of hormone delivery and frequency of admin-
istration (weekly for the transdermal patch and monthly
for the vaginal ring) [7, 8]. Hormone released
the transdermal patch or the vaginal ring is independent
of gastrointestinal absorption, while transvaginal absorp-
tion—when using the ring—also provides a substantial re-
duction of the daily fluctuations in steroid levels observed
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with COCs, allowing the use of lower doses of ethinyles-
tradiol [9, 10].
However, women’s knowledge of newer contraceptive
methods is still limited. Indeed, the wide range of contra-
ceptive options available today makes the process of selec-
tion an increasingly difficult task. Many factors also affect
the choice of a contraceptive: efficacy in preventing preg-
nancy and safety/tolerability are obviously important, but
so are ease of use, convenience, effects on menstrual bleed-
ing, benefits or risks for general health (true or perceived),
as well as partners’ or peers’ attitudes [3, 4, 11, 12]. Socio-
cultural and personal factors also play an important role in
the choice of a birth control method [6, 13].
Adequate information from healthcare professionals
(HCPs), through counselling, is an essential step in
helping women to select the contraceptive method that
best suits their individual needs [14]. Counselling may
clarify doubts or erroneous perceptions, and allow
counsellors to suggest the best method for a woman’s
clinical profile and lifestyle, and encourage an open
dialogue about sexual well-being. Counselling may also
anticipate common concerns that may arise after start-
ing a particular method, thus setting realistic expecta-
tions about possible adverse events (AEs) and reducing
the need for post-counselling contact with physician
offices (callbacks).
Recently, the Contraceptive Health Research of In-
formed Choice Experience (CHOICE) study assessed the
effect of structured counselling on personal contracep-
tive decisions, and explored the reasons for these
choices. In that study, counselling increased the use of
alternative CHCs, though there were substantial differ-
ences between countries. The CHOICE study was con-
ducted in a group of 11 European countries that did not
include Italy.
Italy has one of the lowest rates of COC use in Europe
(15.2 %) [1], and the aim of the present study, the Educa-
tional COunselling effectS (ECOS) study, was to assess the
effects of structured counselling provided by gynaecolo-
gists on selection of a CHC method (pill, transdermal
patch or vaginal ring) by women from Italy.
Methods
Design
This observational, prospective study was conducted in
16 gynaecology centres (in hospitals or public health
centres throughout Italy, see Additional file 1) between
November 11, 2010 and October 30, 2012. The objective
of the study was to monitor the effects of counselling on
combined hormonal contraceptive choice using a stan-
dardised counselling questionnaire (see Additional file 2)
and guide. The study was conducted in accordance
with European regulations regarding non-interventional
studies, and the protocol was reviewed and approved
by independent ethics committees for all centres. The
study consisted of a screening phase and an observa-
tional phase. The screening phase followed method-
ology established in the European CHOICE study [15].
During the observational phase, physicians recorded all
callbacks and the reasons for calling back.
Participants
Healthy women aged ≥18 and ≤40 years who were con-
sidering starting a pill, transdermal patch or vaginal ring
CHC method (or re-starting one after a ≥1-month sus-
pension), who were not interested in initiating a preg-
nancy in the next 3 months and who agreed to complete
a questionnaire were invited to participate in the study.
Women who consulted their physician to stop a CHC
method could not participate (unless they intended to
switch from one COC to another method). Women who
requested a CHC method but for whom the gynaeco-
logist considered another method more appropriate
(e.g., presence of contraindications for CHC) were appro-
priately counselled but still completed the questionnaire.
Women were asked to sign an informed consent form
prior to enrolment.
Observational measures
At the start of the observation phase, physicians
compiled part A of the questionnaire with information
on which method the participant intended to use (if
any), as well as whether CHC was indicated for this
participant and whether the counselling leaflet was
used (see Additional file 3).
The counselling leaflet (an Italian translation of the
one used in the European CHOICE study [15] which
had been developed in consultation with the European
Society of Contraception and Reproductive Health) [12],
and presented a comprehensive and balanced overview
of the three CHC methods, including reference to alter-
native progestogen-only methods. Counselling provided
concise information on mode of action, frequency of
administration, proper use, efficacy, tolerability, potential
risks and benefits, suitability for individual needs and
other features that the gynaecologist might consider
important for the individual woman.
Subsequently, the subjects compiled part B of the
questionnaire, in which they provided demographic in-
formation, including age, educational level, employment
status, number of children, wish to have children in the
future, history of unplanned pregnancies or abortions,
the presence of a partner and the most recently used
contraceptive method. They indicated which method (if
any) they had chosen, the reasons for selecting that
method and the reasons for not choosing the other
contraceptive options. They then provided their percep-
tions about the three CHC methods (pill, transdermal
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patch or vaginal ring). Perceptions were investigated by
means of multiple-choice statements (strongly agree,
agree, no opinion, disagree, strongly disagree, do not
know) to the following eight statements about each
method: The method prevents pregnancy effectively; has
many side effects; can be dangerous for your health; is
easy to use; is easy to forget; gives you regular menstrual
bleeding; protects against certain forms of cancer; many
women use the method.
The study also included a 4-month follow-up, during
which data on the number of users who contacted the
physician’s office to report concerns, problems or ad-
verse events with the chosen contraceptive method (i.e.,
callbacks) were collected. The reasons for calling were
grouped in four major categories: side effects, non-
compliant behaviour, doubts or fears, and other reasons.
Low callback rates were considered an indicator of both
satisfaction and counselling clarity; moreover, it was
hypothesized that callback rates might differ depending
on the chosen method.
All AEs reported during the 4-month follow-up were
collected according to regulations on spontaneous report-
ing in a postmarketing setting and reported on the case
report form, specifying the duration and severity of
each event, and its relationship to the study treatment.
The study was approved by the Ethics Committee of
Azienda Universitaria Careggi, Divisione Clinica Ostetrica,
Florence, Italy.
Statistical analyses
Statistical analyses were performed using descriptive
methods. Absolute frequency distributions of hormonal
contraceptive method chosen by patients before and after
counselling (the principal endpoint of the study) are
presented. Difference in distribution of CHC methods
before and after counselling was tested with McNemar’s
chi-squared tests and presented with two-sided 95 %
confidence intervals (CIs). The differences in proportions
for the pre- versus post-counselling choice were assessed
at a one-sided significance level of 1.25 % (significance
adjusted for multiple comparisons). Descriptive statistics
on all characterisation variables were provided overall and
for each post-counselling CHC group. For the exploratory
analyses a two-sided significance level of 5 % was used.
With regard to callbacks, patients who called back more
than once and those having multiple complaints were
counted overall and for each method.
Demographic and social variables were evaluated (e.g.,
age, weight, place of residence, marital status, education,
employment status, number of children, planning of
future pregnancies, unintended pregnancies, abortions
and stability of relationship with partner).
Based on data on contraceptive use in Italy, where ap-
proximately 20 % of women consulting their physicians
would be interested in a CHC method [6] (and consid-
ering an 80–90 % prevalence of COC reported in the
2010 IMS Health Report), a sample size of 1850 women
was deemed sufficient to detect a difference post- versus
pre-counselling for ring or patch of 3 % with an overall
power of 90 %. This sample size also permitted assessment
of a 10 % callback rate reduction in the vaginal ring group
versus the pill group as significant (alpha = 0.05, power =
80 %). All analyses were performed with the SAS
(version 8) statistical software package.
Results
Participants
A total of 1919 women were included in the observa-
tional phase. Their characteristics are summarised in
Table 1. Before the consultation, the most frequently
used contraceptive method was the pill (36.8 %),
followed by condoms (28.3 %), while 18.2 % of women
had never previously ever used contraceptive methods.
The transdermal patch and the vaginal ring had been
used, respectively, by 1.8 and 2.7 % of women. Physicians
did not consider CHC to be a suitable method for 48
(2.5 %) participating women, mainly due to the presence
of contraindications or medical conditions. In all, 1871
(97.5 %) were included in the analyses.
Contraceptive choice prior to counselling
Before the counselling session, most women were ori-
ented toward using the pill (64.5 %), while 18.0 % were
undecided. Intentions to use the transdermal patch and
the vaginal ring were expressed by 3.2 and 5.2 %,
respectively (Table 2).
Contraceptive choice post-counselling
After counselling, the pill was chosen as contraceptive
method by 64.1 % of women, the transdermal patch by
7.0 % and the vaginal ring by 21.2 % (Table 3). Non-
CHC methods were chosen by 5.6 % of subjects, while
2.1 % remained undecided. Compared with the inten-
tions manifested before counselling, the proportion of
women choosing the pill remained practically unchanged,
while preferences for the other methods increased signifi-
cantly (p < 0.0001), by approximately two-fold for the
transdermal patch and by four-fold for the vaginal ring.
Counselling also significantly decreased the percentage of
women who originally intended to use other methods or
were undecided (p < 0.0001).
Among women who originally intended to use the
pill, 81.2 % actually chose the pill, whereas 13.8 % opted
for the vaginal ring and 2.8 % for the transdermal patch
(Table 3). Among women who originally intended to
use the transdermal patch, 48.3 % actually chose this,
while the other half opted for the pill (23.3 %) or vagi-
nal ring (26.7 %). Most women who were initially
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oriented to use the vaginal ring actually selected this
method (87.6 %), with only a small percentage opting
for the pill (4.1 %) or the transdermal patch (5.2 %). In
the group of women who were initially undecided, most
were able to make a choice after counselling: 42.6 %
opted for the pill, 24.4 % for the vaginal ring and
15.5 % for the transdermal patch.
The reasons for choosing/not choosing the pill, the
patch and the ring are summarised in Figs. 1, 2 and 3,
respectively.
The information received during counselling was rated
as very useful, complete and fair/balanced by 67.2, 63.0
and 62.4 % of participants, respectively, while 29.2, 33.0
and 31.4 %, respectively, rated it as sufficiently useful,
complete and fair/balanced. The counselling leaflet was
used in 85.6 % of all consultations; specifically, it was
not used for users who requested a switch from one
COC to another COC. Users were asked to rate the use-
fulness, completeness, and fairness of the information
provided using a scale (very, sufficiently, neutral, not
very, not at all). A high proportion of users had positive
responses: very or sufficiently useful (96.4 %), very or
sufficiently complete (96.0 %), and very or sufficiently
fair/balanced (93.8 %).
Effect of baseline characteristics as predictors for
post-counselling contraceptive choice
No predictors of post-counselling contraceptive choice
could be identified. The four groups (daily pill, transdermal
Table 1 Baseline characteristics of the study population
Parametera Participants (n = 1919)
Age, years, mean (SD) 26.6 (6.3)




Marital status, n (%)





Primary school 60 (3.1)
Secondary school 432 (22.5)
High school graduate 987 (51.4)
Bachelor’s degree 327 (17.0)
Employment status, n (%)
None 95 (5.0)
Part-time employment 153 (8.0)










Planning future pregnancies, n (%)b
Yes 1367 (71.5)
No 271 (14.2)
Do not know yet 260 (13.6)















Stable relationship with partner, n (%)b
Yes 1555 (81.3)
No 346 (18.1)
Last contraceptive method use, n (%)b
Combined oral contraceptive pill 704 (36.8)
Condoms 542 (28.3)
Natural family planning 153 (8.0)
Vaginal ring 52 (2.7)
Transdermal patch 35 (1.8)
Copper-releasing intrauterine device 29 (1.5)
Progestogen-only pill 23 (1.2)
Levonorgestrel-releasing intrauterine system 13 (0.7)
Injectable 6 (0.3)
Contraceptive implant 2 (0.1)
No method 348 (18.2)
aSome variables were missing or not reported
b1913 subjects analysed
c1498 subjects analysed
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patch, vaginal ring and other methods) did not differ with
regard to age, weight and place of residence (rural vs
urban). Unmarried women, who represented nearly 75 %
of the study population, preferred the pill (with 80.8 % of
subjects choosing the pill being unmarried) and the ring
(72.5 %), with similar rates of preferences for the patch
(63.4 %) or a method yet to be decided (67.5 %), while
married women preferred other methods (42.3 %). The
majority of women with a high school diploma or bache-
lor’s degree preferred the vaginal ring (50.6 and 23.7 %, re-
spectively) or the daily pill (55.0 and 16.0 %, respectively).
Students preferred the pill (40.4 %) or the ring (31.5 %).
The majority of women who preferred the pill or the ring
had never experienced an unplanned pregnancy (84.3 and
74.2 %, respectively) or an abortion (86.3 and 74.9 %, re-
spectively). The stability/instability of the relationship
with a partner did not appear to influence the choice of
contraceptive method.
Follow-up
During the 4-month follow-up period, the rate of call-
backs for each method was calculated. Overall, there
was a low rate of callbacks for any reason, with no sig-
nificant differences among groups. The proportion of
women calling their physician’s office about side effects
was 2.2 % for pill users, 1.0 % for vaginal ring users and
3.1 % for transdermal patch users, while calls for non-
compliant behaviour (missing/delayed doses of pill or in-
correct application/insertion/removal of ring or patch)
were made by 1.1 % of pill users, 1.8 % of vaginal ring
users and 0 % of transdermal patch users (Table 4). Only
the rate of callbacks related to doubts/fears differed sig-
nificantly among groups, being highest among women
who had chosen the transdermal patch (3.1 %, vs 0.7 %
of pill users and 2.5 % of vaginal ring users; p < 0.05).
Safety evaluation
The incidence of AEs was very low in all contraceptive
groups and the most frequent organ system affected was
the reproductive system (Table 5). Women who chose
the vaginal ring experienced the lowest rate of AEs
(1.8 %, compared with 2.3 % for pill users and 3.1 % for
transdermal patch users). No severe AEs were reported;
35 were graded as mild and 10 as moderate. There was a
similar distribution of mild and moderate AEs among
study groups.
Discussion
This is the largest study exploring women’s preferences
and perceptions about different CHC methods in Italy
since the multinational survey by Skouby et al. published
in 2004 [6]. Preferences for the pill remained subs-
tantially unchanged in our study (from 64.5 % pre- to
64.1 % post-counselling), while the percentages of
women who were oriented to use the transdermal patch
(3.2 %)or the vaginal ring (5.2 %) were low initially but
increased significantly post-counselling by approximately
two-fold for the transdermal patch (7.0 %) and four-fold
for the vaginal ring (21.2 %). Similarly, counselling sig-
nificantly reduced the proportion of women who initially
intended to use a non-CHC method (from 9.1 to 5.6 %)
or were undecided (from 18.0 to 2.1 %). Preferences for
Table 2 Comparison of intended (pre-counselling) versus chosen (post-counselling) contraceptive method
Method Pre-counselling Post-counselling Difference p-value (McNemar’s test)
n (%) n (%) (95 % CI)
Pill 1207 (64.5) 1199 (64.1) −0.4 (−2.6 to 1.8) 0.71
Transdermal patch 60 (3.2) 131 (7.0) 3.8 (2.6 to 5.0) <0.0001
Vaginal ring 97 (5.2) 397 (21.2) 16.0 (14.3 to 17.8) <0.0001
Other method 171 (9.1) 104 (5.6) −3.6 (−5.0 to −2.2) <0.0001
Undecided 336 (18.0) 40 (2.1) −15.8 (−17.6 to 14.1) <0.0001




Pill Patch Ring Other method Undecided
n (%) n (%) n (%) n (%) n (%)
Pill (64.5)a 980 (81.2) 34 (2.8) 166 (13.8) 21 (1.7) 6 (0.5)
Transdermal patch (3.2)a 14 (23.3) 29 (48.3) 16 (26.7) 1 (1.7) 0
Vaginal ring (5.2)a 4 (4.1) 5 (5.2) 85 (87.6) 2 (2.1) 1 (1.0)
Other method (9.1)a 58 (33.9) 11 (6.4) 48 (28.1) 48 (28.1) 6 (3.5)
Undecided (18.0)a 143 (42.6) 52 (15.5) 82 (24.4) 32 (9.5) 27 (8.0)
1199 (64.1)a 131 (7.0)a 397 (21.2)a 104 (5.6)a 40 (2.1)a
aPre- and post-counselling total percentages are in bold
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the vaginal ring remained unchanged post-counselling in
87.6 % of women (compared with 81.2 % for the pill and
48.3 % for the transdermal patch), while a shift in favour
of the vaginal ring was registered in 13.8 and 26.7 % of
intended pill and transdermal patch users, respectively.
Overall, 38 % of the women selected a CHC method that
was different from the one they initially intended to use.
These data reflect the findings of recent studies
conducted on CHC choice. In the largest of these
investigations, the Contraceptive Health Research of
Informed Choice Experience (European CHOICE)
study, which collected data from more than 18,000
women in 11 countries (not including Italy), after
counselling, 47 % of participants selected a CHC
method different from the one originally planned,
with significant increases in transdermal patch use
from 5 to 8 %, and in vaginal ring use from 8 to
30 % (p < 0.0001 for both methods) [14]. Great differ-
ences were noted among participating countries, al-
though an increase in preferences for the transdermal
patch or the vaginal ring was observed in all countries.
This trend was also observed in a Brazilian study,
Fig. 1 Main reasons for choosing the pill (a) and reasons for NOT choosing the pill versus method chosen (b) (percent of women stating
each reason)
Gambera et al. BMC Women's Health  (2015) 15:69 Page 6 of 11
where counselling induced an even more marked shift
from COC (from 66.5 to 53.7 %) in favour of other
methods (from 8.9 to 14 % for the transdermal patch
and from 6.7 to 16 % for the vaginal ring) [16].
In our study, the participants rated the counselling ex-
perience positively, with >93 % of women considering
the quality of the information received to be either very
or adequately useful, complete, and fair and balanced.
The importance of individualised counselling for select-
ing an appropriate contraceptive method has been
highlighted in numerous studies. In one multinational
survey designed to assess attitudes and preferences of a
large population of CHC users, knowledge about the
range of available contraceptive methods was often lim-
ited, even in women already using CHC, and 53–73 %
expressed an interest in learning more about alternative
Fig. 2 Main reasons for choosing the patch (a) and reasons for NOT choosing the patch versus method chosen (b) (percent of women stating
each reason)
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contraceptive delivery methods in general [3]. Despite the
increasing availability of the Internet and the recognised
role of media and peers as sources of information, HCPs
(mostly gynaecologists in Italy) maintain a primary role in
guiding women in the process of decision-making about
contraceptives, as documented in recent studies [4, 14]. In
our study, counselling empowered undecided women to
make a choice and encouraged the participants to consider
Fig. 3 Main reasons for choosing the ring (a) and reasons for NOT choosing the ring versus method chosen (b) (percent of women stating
each reason)
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alternative CHC methods, although preferences for the pill
remained substantially unchanged. The biggest change
from pre-counselling intentions was the increase in prefer-
ences for the vaginal ring, as this was the final choice for a
substantial number of women who had initially intended
to use another method (Table 3).
When the reasons for selecting a particular method
were analysed, prominent reasons (i.e., indicated by
>30 % of subjects) for choosing the pill were found to be
ease of use, possibility of regular menstrual bleeding,
daily use, relief from menstrual pain and being a well-
researched method. The main reasons in favour of the
transdermal patch were ease of use, weekly use and low
chance of forgetting to apply it, while those for choosing
the vaginal ring were monthly use, low chance of forget-
ting to insert it, ease of use, steady/low hormonal levels,
retained effectiveness in case of vomiting or diarrhoea
and possibility of regular menstrual bleeding. These find-
ings are in agreement with findings from similar investi-
gations, in particular an analysis of the CHOICE study
revealed that the perceived ease of use of a method (in-
cluding preferences in dosing frequency) is often more
important than considerations strictly related to efficacy,
tolerability and general health benefits/risks [11]. How-
ever, it should be noted that in our study approximately
one-third of women who chose the vaginal ring after
counselling cited other benefits offered by this method:
steady and low hormone dosage, effectiveness irres-
pective of vomiting/diarrhoea, and regular menstrual
bleeding. Likewise, regular menstrual bleeding was an
important motivation for more than half of the women
choosing the pill.
The reasons for not choosing a particular method also
provide important insights into contraceptive selection
criteria. As expected, the main reasons for not selecting
the pill (vs the method chosen) were daily administra-
tion and high chance of forgetting to take it. The main
reasons against choosing the transdermal patch were its
visibility and the possibility of it falling off, while the
main reasons not to select the vaginal ring were dislike
of the insertion of a foreign body and feeling uncomfort-
able with vaginal insertion. While some of the reasons
indicated for not choosing a method are intrinsic charac-
teristics of that method (e.g., dosing frequency), negative
perceptions about the vaginal ring are subjective feelings
that could be modified by counselling. Topics related to
sexuality and vaginal manipulation are notoriously diffi-
cult to discuss and require well-developed communica-
tion skills from information providers, as most women
are uncomfortable talking about these issues with their
HCPs. However, an open dialogue about vaginal anat-
omy and functions could greatly improve women’s body
knowledge and help them take full advantage of all avail-
able contraceptive options [17].
A unique feature of our study was the inclusion of a
4-month follow-up period during which callbacks to the
gynaecologist’s office and the reasons motivating them were
recorded. Callback rates have been used to gauge user satis-
faction with CHC [18]. Overall, the rate of callbacks was
Table 4 Reasons for callbacks to the gynaecologists’ office
during the 4-month follow-up
Callback reason Pill Patch Ring p-value
(n = 1199) (n = 131) (n = 397) (Chi-square test)
n (%) n (%) n (%)
All reasonsa 61 (5.1) 9 (6.9) 24 (6.0) 0.66
Doubts, fears 8 (0.7) 4 (3.1) 10 (2.5) <0.05
Non-compliant
behaviourb
13 (1.1) 0 7 (1.8) 0.24
Other reasons 16 (1.3) 1 (0.8) 3 (0.8) 0.59
Side effects 26 (2.2) 4 (3.1) 4 (1.0) 0.23
aPatients were counted once within ‘All reasons’ and for each specific reason
bMissing/delays in taking pill or application/insertion or removal of
transdermal patch/vaginal ring
Table 5 Adverse events reported during 4-month follow-up by system organ class
System organ class/preferred term Pill Patch Ring
(n = 1199) (n = 131) (n = 397)
n (%) Events n (%) Events n (%) Events
n n n
All 28 (2.3) 30 4 (3.1) 5 7 (1.8) 10
Cardiac disorders 0 0 0 0 1 (0.3) 1
Gastrointestinal disorders 2 (0.2) 2 0 0 1 (0.3) 1
Infections/infestations 0 0 0 0 1 (0.3) 1
Investigations 4 (0.3) 4 0 0 0 0
Metabolism and nutrition disorders 1 (0.1) 1 0 0 0 0
Nervous system disorders 9 (0.8) 9 1 (0.8) 1 2 (0.5) 3
Psychiatric disorders 1 (0.1) 1 0 0 1 (0.3) 1
Reproductive system and breast disorders 12 (1.0) 13 4 (3.1) 4 3 (0.8) 3
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low (≤6 %), suggesting that counselling may have explained
how to deal with potential problems and anticipated con-
cerns that were likely to arise during initial use. However,
about one third of women had used some form of CHC
previously and this might have contributed to the low rate.
The small number of callbacks and relatively small number
of patch and ring users precludes meaningful comparison
among the methods.
All methods appeared to be well-tolerated during the
follow-up period, with a percentage of women contacting
their physicians for AEs ranging from 1 % among vaginal
ring users to 3 % among transdermal patch users. The
only significant difference among contraceptive groups
was a higher rate of callbacks regarding doubts or fears
among transdermal patch users. The tolerability of the
three contraceptive options was confirmed by the low in-
cidence of reported AEs and the lack of severe AEs.
This study has limitations that should be acknowledged,
some intrinsic to the study design. Like many similar inves-
tigations, we included only women who were interested in
starting or re-starting CHC. Women who were oriented to-
ward other forms of contraception were excluded a priori
from the investigation, as were very young women or those
aged ≥40 years. These results, therefore, cannot be general-
ised to the whole population of women seeking advice
about contraception in Italy. Also, we did not investigate
background characteristics of the participating gynaecolo-
gists, such as personal contraceptive preferences (which are
known to influence recommendations) [19], nor did we
compare each woman’s choice with the method recom-
mended or suggested (if any) by her gynaecologist. The
opinions of HCPs have a profound impact on contracep-
tive decisions of women they counsel [14]. Therefore, we
cannot, rule out a bias toward recommending alternatives
to COCs among participating gynaecologists. However,
most women rated the quality of the information provided
during counselling as fair and balanced. Furthermore, a
relatively low percentage of women (8–23 %) indicated
physician’s recommendation as a reason for choosing a
contraceptive. Finally, the 4-month follow-up period
included in this study was inadequate for a complete
assessment of satisfaction, tolerability and compliance
with the chosen method. However, these were not the
study aims. Problems related to the use of a new
contraceptive are more frequent during the initial phase
and are expected to decline with time. The observation
period was sufficient to judge whether counselling had
made women more comfortable with their chosen CHC
method and to record doubts or concerns and AEs
experienced during this initial period.
Conclusions
Our findings provide further evidence that well-structured
and balanced counselling can influence the choice of
CHC. When adequately informed, a substantial number
of women will select a CHC option that is different
from the originally intended one, and that this choice is
often in favour of alternatives to COCs. HCPs should
be proactive when counselling on the benefits and risks
associated with the use of hormonal contraceptives,
and should also consider what women think about the
effects of CHCs on their health and wellbeing.
Counselling encourages appropriate use and adher-
ence, and may prevent unplanned pregnancies that re-
sult from inconsistent or incorrect use of contraceptives.
The pill, the transdermal patch, and the vaginal ring are
the currently available and commonly used combined
hormonal contraceptives (CHCs). Although all are ef-
fective when used properly, incorrect and irregular use
contributes greatly to their failure. The consequent un-
intended pregnancies may be preventable though effect-
ive counselling about contraception.
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